1-5 of 5
Martin J Glennie, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-CD27 Enhances Lymphoma Immunotherapy through Profound Myeloid Cell Recruitment

Anna H Turaj, MSc, Vikki L Field, Claude H.T. Chan, PhD, Christine A. Penfold, BSc, Jinny H. Kim, PhD, Sonya James, PhD, Kerry L Cox, Tibor Keler, PhD, Peter M Johnson, MA, MD, Aymen Al-Shamkhani, PhD, Stephen A Beers, PhD, Martin J. Glennie, PhD, Mark S Cragg, PhD, Sean H Lim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3024.
https://doi.org/10.1182/blood.V128.22.3024.3024
Published: 2016
Journal Articles

Non-Cognate Cytotoxic T Cells Can Be Retargeted Against CD20 Positive Tumour Cells Using [Fab' × MHC Class I/Peptide] Conjugates.

Angela D Hamblin, BA, MRCP, Ben CR King, PhD, Ruth R French, PhD, Claude H Chan, PhD, Alison L Tutt, MPhil, Philip M Savage, PhD, FRCP, Peter W Johnson, MD, FRCP, Martin J Glennie, PhD
Journal: Blood
Blood (2010) 116 (21): 2838.
https://doi.org/10.1182/blood.V116.21.2838.2838
Published: 2010
Journal Articles

New-Generation Anti-CD20 Monoclonal Antibody (GA101) Evokes Homotypic Adhesion and Actin-Dependent, Lysosome-Mediated Cell Death in B-Cell Lymphoma.

Waleed Alduaij, MRes, Sandeep Potluri, BA, Andrei Ivanov, PhD, Jamie Honeychurch, PhD, Stephen A Beers, PhD, Claude Chan, PhD, Kazayuki Shimada, MD, Martin J. Glennie, PhD, Mark S Cragg, PhD, Tim Illidge, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 725.
https://doi.org/10.1182/blood.V114.22.725.725
Published: 2009
Journal Articles

Novel Mechanisms of Non-Apoptotic Cell Death Evoked by Type II Anti-CD20 (Tositumomab) and HLA-DR Monoclonal Antibodies

Tim Illidge, MD, PhD, Andrei Ivanov, PhD, Stephen A Beers, PhD, Claire Walshe, PhD, Claude Chan, PhD, Waleed Alduaij, Martin J. Glennie, PhD, Mark S Cragg
Journal: Blood
Blood (2008) 112 (11): 883.
https://doi.org/10.1182/blood.V112.11.883.883
Published: 2008
Journal Articles

Cyclophosphamide Induced CD11b + Cells Can Inhibit Anti-CD40 Monoclonal Antibody (mAb) Therapy of B-Cell Lymphoma.

Jamie Honeychurch, PhD, Martin J. Glennie, PhD, Peter W. Johnson, MD, Tim M. Illidge, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3280.
https://doi.org/10.1182/blood.V104.11.3280.3280
Published: 2004